RXL vs. CURE

Last updated Apr 1, 2026

Compare and contrast key facts about ProShares Ultra Health Care (RXL) and Direxion Daily Healthcare Bull 3x Shares (CURE).

RXL and CURE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. RXL is a passively managed fund by ProShares that tracks the performance of the Dow Jones U.S. Health Care Index (200%). It was launched on Jan 30, 2007. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. Both RXL and CURE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

RXL vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Health Care (RXL) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

RXL vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RXL ProShares Ultra Health Care	-11.22%	19.76%	-2.72%	-3.15%	-15.26%	48.06%	19.24%	40.40%	3.38%	46.92%
CURE Direxion Daily Healthcare Bull 3x Shares	-17.66%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%

Returns By Period

In the year-to-date period, RXL achieves a -11.22% return, which is significantly higher than CURE's -17.66% return. Over the past 10 years, RXL has underperformed CURE with an annualized return of 12.57%, while CURE has yielded a comparatively higher 13.32% annualized return.

RXL

• 1D: 3.92%
• 1M: -16.20%
• YTD: -11.22%
• 6M: 8.56%
• 1Y: -3.95%
• 3Y*: 3.48%
• 5Y*: 3.69%
• 10Y*: 12.57%

CURE

• 1D: 5.69%
• 1M: -23.73%
• YTD: -17.66%
• 6M: 10.27%
• 1Y: -12.92%
• 3Y*: -0.17%
• 5Y*: 3.15%
• 10Y*: 13.32%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RXL vs. CURE - Expense Ratio Comparison

RXL has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.

CURE

Direxion Daily Healthcare Bull 3x Shares

RXL

ProShares Ultra Health Care

Return for Risk

RXL vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXL

RXL Risk / Return Rank: 10
RXL Sharpe Ratio Rank: 10
RXL Sortino Ratio Rank: 11
RXL Omega Ratio Rank: 11
RXL Calmar Ratio Rank: 10
RXL Martin Ratio Rank: 10

CURE

CURE Risk / Return Rank: 9
CURE Sharpe Ratio Rank: 8
CURE Sortino Ratio Rank: 10
CURE Omega Ratio Rank: 10
CURE Calmar Ratio Rank: 8
CURE Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RXL vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Health Care (RXL) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RXL	CURE	Difference
Sharpe ratio Return per unit of total volatility	-0.11	-0.25	+0.13
Sortino ratio Return per unit of downside risk	0.09	0.00	+0.08
Omega ratio Gain probability vs. loss probability	1.01	1.00	+0.01
Calmar ratio Return relative to maximum drawdown	-0.13	-0.28	+0.15
Martin ratio Return relative to average drawdown	-0.24	-0.50	+0.26
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RXL vs. CURE - Sharpe Ratio Comparison

The current RXL Sharpe Ratio is -0.11, which is higher than the CURE Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of RXL and CURE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RXL	CURE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.11	-0.25	+0.13
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.13	0.07	+0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.27	+0.11
Sharpe Ratio (All Time) Calculated using the full available price history	0.40	0.47	-0.07

Correlation

The correlation between RXL and CURE is 0.97, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Dividends

RXL vs. CURE - Dividend Comparison

RXL's dividend yield for the trailing twelve months is around 1.64%, more than CURE's 1.30% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RXL ProShares Ultra Health Care	1.64%	1.43%	1.22%	0.18%	0.32%	0.10%	0.15%	0.27%	0.32%	0.11%	0.12%	0.93%
CURE Direxion Daily Healthcare Bull 3x Shares	1.30%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%

Drawdowns

RXL vs. CURE - Drawdown Comparison

The maximum RXL drawdown since its inception was -67.70%, roughly equal to the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for RXL and CURE.

Drawdown Indicators

	RXL	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-67.70%	-69.19%	+1.49%
Max Drawdown (1Y) Largest decline over 1 year	-22.73%	-33.92%	+11.19%
Max Drawdown (5Y) Largest decline over 5 years	-36.08%	-52.23%	+16.15%
Max Drawdown (10Y) Largest decline over 10 years	-51.00%	-69.19%	+18.19%
Current Drawdown Current decline from peak	-19.31%	-34.64%	+15.33%
Average Drawdown Average peak-to-trough decline	-15.82%	-17.94%	+2.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.51%	20.16%	-7.65%

Volatility

RXL vs. CURE - Volatility Comparison

The current volatility for ProShares Ultra Health Care (RXL) is 9.36%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 13.92%. This indicates that RXL experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RXL	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.36%	13.92%	-4.56%
Volatility (6M) Calculated over the trailing 6-month period	21.09%	30.96%	-9.87%
Volatility (1Y) Calculated over the trailing 1-year period	35.48%	52.88%	-17.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	29.33%	43.34%	-14.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.19%	49.47%	-16.28%